https://stock.noler.com/us/stock/china-pharmaceuticals-inc https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accounts-payable-other-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accrued-salaries-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/china-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/china-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/china-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/china-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/china-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/china-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/china-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/china-pharmaceuticals-inc/assets-noncurrent https://stock.noler.com/us/stock/china-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/china-pharmaceuticals-inc/buildings-and-improvements-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/business-acquisition-equity-interest-issued-or-issuable-value-assigned https://stock.noler.com/us/stock/china-pharmaceuticals-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/china-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/china-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/china-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/china-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/china-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/china-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/china-pharmaceuticals-inc/construction-in-progress-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/china-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/china-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/china-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/china-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/china-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/china-pharmaceuticals-inc/deferred-income-taxes-and-other-assets-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/deferred-income-taxes-and-other-assets-noncurrent https://stock.noler.com/us/stock/china-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/china-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/china-pharmaceuticals-inc/deposits-assets-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/china-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/china-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/china-pharmaceuticals-inc/due-from-officers-or-stockholders-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/china-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/china-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/china-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/china-pharmaceuticals-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/fixtures-and-equipment-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/china-pharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/china-pharmaceuticals-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/china-pharmaceuticals-inc/impairment-of-real-estate https://stock.noler.com/us/stock/china-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/china-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/china-pharmaceuticals-inc/income-taxes-receivable https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-deposits-outstanding https://stock.noler.com/us/stock/china-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/china-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/china-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/china-pharmaceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/china-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/china-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/china-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/china-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/china-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/china-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/china-pharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/china-pharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/china-pharmaceuticals-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/china-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/china-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/china-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/china-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/china-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/china-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/china-pharmaceuticals-inc/other-employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/china-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/china-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/china-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/china-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/china-pharmaceuticals-inc/payments-for-construction-in-process https://stock.noler.com/us/stock/china-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/china-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/prepaid-expense-other-noncurrent https://stock.noler.com/us/stock/china-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/china-pharmaceuticals-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/china-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/china-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/china-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/china-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/china-pharmaceuticals-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/china-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/china-pharmaceuticals-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/china-pharmaceuticals-inc/retained-earnings-appropriated https://stock.noler.com/us/stock/china-pharmaceuticals-inc/retained-earnings-unappropriated https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sales-and-excise-tax-payable-current https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-10ksb https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-10qsb https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-def-14c https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-revoked https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/china-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/china-pharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/china-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/china-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/china-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/china-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/china-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/china-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/china-pharmaceuticals-inc/short-term-borrowings https://stock.noler.com/us/stock/china-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/china-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/china-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/china-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/china-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/china-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/china-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/china-pharmaceuticals-inc/tax-rate-reconciliation-tax-holidays https://stock.noler.com/us/stock/china-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/china-pharmaceuticals-inc/total-liabilities-and-equity